You are here

  • Home
  • Archive
  • Volume 67, Issue 1
  • Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

Article metrics

Article menu

Download PDFPDF

Inflammatory bowel disease
Original article
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC
Free

 

Online download statistics by month:

Online download statistics by month: October 2016 to September 2023

AbstractFullPdf
Oct 20169633891
Nov 2016353115130
Dec 201629647299
Jan 201721759235
Feb 20171213727
Mar 2017965632
Apr 2017793823
May 2017995745
Jun 2017714626
Jul 20171453317
Aug 20171664422
Sep 20171494840
Oct 20171603521
Nov 20171482516
Dec 2017655539161
Jan 2018452344164
Feb 201832619987
Mar 201820317081
Apr 201822317084
May 201826923566
Jun 201817816066
Jul 201818415248
Aug 2018209181100
Sep 201820819444
Oct 201819116262
Nov 201812412255
Dec 201813513550
Jan 201913813464
Feb 201913513669
Mar 201915214698
Apr 201913012767
May 201915215054
Jun 201913313159
Jul 201914613878
Aug 20191109848
Sep 201910710244
Oct 201916715260
Nov 20191039849
Dec 201912911666
Jan 202017716291
Feb 20201149445
Mar 202012811469
Apr 202011811474
May 2020110104226
Jun 2020128105143
Jul 2020160145100
Aug 2020968262
Sep 202013510136
Oct 20201018585
Nov 202010810260
Dec 202011910447
Jan 2021766955
Feb 2021837161
Mar 202112111768
Apr 202111610866
May 202111911474
Jun 202111111165
Jul 202111711665
Aug 2021938860
Sep 202113713190
Oct 202112311773
Nov 2021192166116
Dec 2021166159141
Jan 202216016194
Feb 202212911765
Mar 2022190200110
Apr 2022222230121
May 202212712587
Jun 202215614773
Jul 202218616962
Aug 202216915475
Sep 2022143140147
Oct 202218016473
Nov 202217516779
Dec 202211310758
Jan 2023999632
Feb 202316213237
Mar 202314312262
Apr 202311810938
May 202311210239
Jun 2023938736
Jul 202313413651
Aug 202314412453
Sep 202314114046
Total14066105776258